Antibody data
- Antibody Data
- Antigen structure
- References [32]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA000536 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA000536, RRID:AB_1080060
- Product name
- Anti-SOX11
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SOX11, Gene description: SRY (sex determining region Y)-box 11, Validated applications: WB, IHC, Uniprot ID: P35716, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Mild hypothermia promotes neuronal differentiation of human neural stem cells via RBM3-SOX11 signaling pathway
Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
A large-scale functional analysis of genes expressed differentially in insulin secreting MIN6 sublines with high versus mildly reduced glucose-responsiveness
miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation
Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia
Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis
SOX11: friend or foe in tumor prevention and carcinogenesis?
SOX11 and SOX4 drive the reactivation of an embryonic gene program during murine wound repair
Impact of Sox11 over-expression in Ba/F3 cells
Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype
Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis
The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases
The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki‐67 index
SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Wilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network
Gene Expression Profiling and Chromatin Immunoprecipitation Identify DBN1, SETMAR and HIG2 as Direct Targets of SOX11 in Mantle Cell Lymphoma
Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms
Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival
Nuclear expression of the non–B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma
From Gene Expression Analysis to Tissue Microarrays
Ma Y, He Z, Wang J, Zheng P, Ma Z, Liang Q, Zhang Q, Zhao X, Huang J, Weng W, Jiang J, Feng J
iScience 2024;27(4):109435
iScience 2024;27(4):109435
Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation
Banerjee D, Bagchi S, Liu Z, Chou H, Xu M, Sun M, Aloisi S, Vaksman Z, Diskin S, Zimmerman M, Khan J, Gryder B, Thiele C
Nature Communications 2024;15(1)
Nature Communications 2024;15(1)
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
Decaesteker B, Louwagie A, Loontiens S, De Vloed F, Bekaert S, Roels J, Vanhauwaert S, De Brouwer S, Sanders E, Berezovskaya A, Denecker G, D’haene E, Van Haver S, Van Loocke W, Van Dorpe J, Creytens D, Van Roy N, Pieters T, Van Neste C, Fischer M, Van Vlierberghe P, Roberts S, Schulte J, Ek S, Versteeg R, Koster J, van Nes J, Zimmerman M, De Preter K, Speleman F
Nature Communications 2023;14(1)
Nature Communications 2023;14(1)
A large-scale functional analysis of genes expressed differentially in insulin secreting MIN6 sublines with high versus mildly reduced glucose-responsiveness
Tanaka A, Kosuda M, Yamana M, Furukawa A, Nagasawa A, Fujishiro M, Kohno G, Ishihara H
Scientific Reports 2023;13(1)
Scientific Reports 2023;13(1)
miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma
Kawaji‐Kanayama Y, Tsukamoto T, Nakano M, Tokuda Y, Nagata H, Mizuhara K, Katsuragawa‐Taminishi Y, Isa R, Fujino T, Matsumura‐Kimoto Y, Mizutani S, Shimura Y, Taniwaki M, Tashiro K, Kuroda J
Cancer Science 2023;115(2):452-464
Cancer Science 2023;115(2):452-464
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation
Gao Y, He X, Wu X, Huang Y, Toneyan S, Ha T, Ipsaro J, Koo P, Joshua-Tor L, Bailey K, Egeblad M, Vakoc C
Nature Cell Biology 2023
Nature Cell Biology 2023
Clinicopathological features and prognostic value of SOX11 in childhood acute lymphoblastic leukemia
Grönroos T, Mäkinen A, Laukkanen S, Mehtonen J, Nikkilä A, Oksa L, Rounioja S, Marincevic-Zuniga Y, Nordlund J, Pohjolainen V, Paavonen T, Heinäniemi M, Lohi O
Scientific Reports 2020;10(1)
Scientific Reports 2020;10(1)
Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis
Dolcetti R, Lee W, Shin E, Kim B, Kim H
PLOS ONE 2019;14(11):e0225096
PLOS ONE 2019;14(11):e0225096
SOX11: friend or foe in tumor prevention and carcinogenesis?
Yang Z, Jiang S, Lu C, Ji T, Yang W, Li T, Lv J, Hu W, Yang Y, Jin Z
Therapeutic Advances in Medical Oncology 2019;11
Therapeutic Advances in Medical Oncology 2019;11
SOX11 and SOX4 drive the reactivation of an embryonic gene program during murine wound repair
Miao Q, Hill M, Chen F, Mo Q, Ku A, Ramos C, Sock E, Lefebvre V, Nguyen H
Nature Communications 2019;10(1)
Nature Communications 2019;10(1)
Impact of Sox11 over-expression in Ba/F3 cells
Lord M, Arvidsson G, Wasik A, Christensson B, Wright A, Grandien A, Sander B
Haematologica 2018;103(12):e594-e597
Haematologica 2018;103(12):e594-e597
Persistence of a t(11;14)‐positive clone in a patient with mantle cell lymphoma for 20 years
Otsuka Y, Nishikori M, Kitano T, Oka T, Ishikawa T, Haga H, Takaori‐Kondo A
Clinical Case Reports 2017;5(4):477-481
Clinical Case Reports 2017;5(4):477-481
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Davidson B, Holth A, Hellesylt E, Tan T, Huang R, Tropé C, Nesland J, Thiery J
Human Pathology 2015;46(1):1-8
Human Pathology 2015;46(1):1-8
Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype
Ribera-Cortada I, Martinez D, Amador V, Royo C, Navarro A, Beà S, Gine E, de Leval L, Serrano S, Wotherspoon A, Colomer D, Martinez A, Campo E
Modern Pathology 2015;28(11):1435-1447
Modern Pathology 2015;28(11):1435-1447
Tripeptidyl Peptidase II Mediates Levels of Nuclear Phosphorylated ERK1 and ERK2
Wiemhoefer A, Stargardt A, van der Linden W, Renner M, van Kesteren R, Stap J, Raspe M, Tomkinson B, Kessels H, Ovaa H, Overkleeft H, Florea B, Reits E
Molecular & Cellular Proteomics 2015;14(8):2177-2193
Molecular & Cellular Proteomics 2015;14(8):2177-2193
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma
Kuo P, Leshchenko V, Fazzari M, Perumal D, Gellen T, He T, Iqbal J, Baumgartner-Wennerholm S, Nygren L, Zhang F, Zhang W, Suh K, Goy A, Yang D, Chan W, Kahl B, Verma A, Gascoyne R, Kimby E, Sander B, Ye B, Melnick A, Parekh S
Oncogene 2014;34(10):1231-1240
Oncogene 2014;34(10):1231-1240
Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma
Nygren L, Baumgartner Wennerholm S, Klimkowska M, Christensson B, Kimby E, Sander B
Blood 2012;119(18):4215-4223
Blood 2012;119(18):4215-4223
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
Carvajal-Cuenca A, Sua L, Silva N, Pittaluga S, Royo C, Song J, Sargent R, Espinet B, Climent F, Jacobs S, Delabie J, Naresh K, Bagg A, Brousset P, Warnke R, Serrano S, Lee Harris N, Swerdlow S, Jaffe E, Campo E
Haematologica 2011;97(2):270-278
Haematologica 2011;97(2):270-278
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis
Ondrejka S, Lai R, Smith S, Hsi E
Haematologica 2011;96(8):1121-1127
Haematologica 2011;96(8):1121-1127
The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases
Cao X, Fan L, Fang C, Zhu D, Dong H, Wang D, Wang Y, Xu W, Li J
Medical Oncology 2011;29(2):1190-1196
Medical Oncology 2011;29(2):1190-1196
The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation
Sernbo S, Gustavsson E, Brennan D, Gallagher W, Rexhepaj E, Rydnert F, Jirström K, Borrebaeck C, Ek S
BMC Cancer 2011;11(1)
BMC Cancer 2011;11(1)
Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki‐67 index
Kimura Y, Sato K, Imamura Y, Arakawa F, Kiyasu J, Takeuchi M, Miyoshi H, Yoshida M, Niino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Ohshima K
Cancer Science 2011;102(9):1734-1741
Cancer Science 2011;102(9):1734-1741
SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies
Gustavsson E, Sernbo S, Andersson E, Brennan D, Dictor M, Jerkeman M, Borrebaeck C, Ek S
Molecular Cancer 2010;9(1)
Molecular Cancer 2010;9(1)
Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Fernàndez V, Salamero O, Espinet B, Solé F, Royo C, Navarro A, Camacho F, Beà S, Hartmann E, Amador V, Hernández L, Agostinelli C, Sargent R, Rozman M, Aymerich M, Colomer D, Villamor N, Swerdlow S, Pileri S, Bosch F, Piris M, Montserrat E, Ott G, Rosenwald A, López-Guillermo A, Jares P, Serrano S, Campo E
Cancer Research 2010;70(4):1408-1418
Cancer Research 2010;70(4):1408-1418
Wilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network
Aiden A, Rivera M, Rheinbay E, Ku M, Coffman E, Truong T, Vargas S, Lander E, Haber D, Bernstein B
Cell Stem Cell 2010;6(6):591-602
Cell Stem Cell 2010;6(6):591-602
Gene Expression Profiling and Chromatin Immunoprecipitation Identify DBN1, SETMAR and HIG2 as Direct Targets of SOX11 in Mantle Cell Lymphoma
Navarro A, Wang X, Björklund S, Wasik A, Grandien A, Andersson P, Kimby E, Dahlman-Wright K, Zhao C, Christensson B, Sander B
PLoS ONE 2010;5(11):e14085
PLoS ONE 2010;5(11):e14085
Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms
Chen Y, Gao J, Fan G, Peterson L
Modern Pathology 2010;23(1):105-112
Modern Pathology 2010;23(1):105-112
Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma
Dictor M, Ek S, Sundberg M, Warenholt J, Gyorgy C, Sernbo S, Gustavsson E, Abu-Alsoud W, Wadstrom T, Borrebaeck C
Haematologica 2009;94(11):1563-1568
Haematologica 2009;94(11):1563-1568
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
Mozos A, Royo C, Hartmann E, De Jong D, Baro C, Valera A, Fu K, Weisenburger D, Delabie J, Chuang S, Jaffe E, Ruiz-Marcellan C, Dave S, Rimsza L, Braziel R, Gascoyne R, Sole F, Lopez-Guillermo A, Colomer D, Staudt L, Rosenwald A, Ott G, Jares P, Campo E
Haematologica 2009;94(11):1555-1562
Haematologica 2009;94(11):1555-1562
The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival
Wang X, Asplund A, Porwit A, Flygare J, Smith C, Christensson B, Sander B
British Journal of Haematology 2008;143(2):248-252
British Journal of Haematology 2008;143(2):248-252
Nuclear expression of the non–B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma
Ek S, Dictor M, Jerkeman M, Jirström K, Borrebaeck C
Blood 2008;111(2):800-805
Blood 2008;111(2):800-805
From Gene Expression Analysis to Tissue Microarrays
Ek S, Andréasson U, Hober S, Kampf C, Pontén F, Uhlén M, Merz H, Borrebaeck C
Molecular & Cellular Proteomics 2006;5(6):1072-1081
Molecular & Cellular Proteomics 2006;5(6):1072-1081
No comments: Submit comment
No validations: Submit validation data